Cargando…
Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
BACKGROUND: Atrial fibrillation (AF) is associated with a risk for cognitive impairment and dementia, which is more pronounced in patients with a history of clinical stroke. Anticoagulation use and efficacy impact long‐term risk of dementia in AF patients in observational trials. METHODS: The cognit...
Autores principales: | Bunch, Thomas Jared, May, Heidi, Cutler, Michael, Woller, Scott C., Jacobs, Victoria, Stevens, Scott M., Carlquist, John, Knowlton, Kirk U., Muhlestein, Joseph B., Steinberg, Benjamin A., Anderson, Jeffrey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745454/ https://www.ncbi.nlm.nih.gov/pubmed/36524040 http://dx.doi.org/10.1002/joa3.12781 |
Ejemplares similares
-
Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study
por: Bunch, T. Jared, et al.
Publicado: (2019) -
Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021) -
Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
por: Ding, Mozhu, et al.
Publicado: (2018) -
Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012) -
Predictors of dementia amongst newly diagnosed non-valvular atrial fibrillation patients
por: Batta, Akash, et al.
Publicado: (2022)